IPRATRIM

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Osta kohe

Laadi alla Infovoldik (PIL)
04-12-2023

Toimeaine:

IPRATROPIUM BROMIDE AS MONOHYDRATE

Saadav alates:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

ATC kood:

R03BB01

Ravimvorm:

INHALER

Koostis:

IPRATROPIUM BROMIDE AS MONOHYDRATE 20 MCG

Manustamisviis:

INHALATION

Retsepti tüüp:

Required

Valmistatud:

LABORATORIO ALDO - UNION, S.L, SPAIN

Terapeutiline ala:

IPRATROPIUM BROMIDE

Näidustused:

IPRATRIM is indicated for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.

Loa andmise kuupäev:

2022-05-23

Infovoldik

                                Patient leaflet in accordance with the Pharmacists’
Regulations (Preparations) - 1986
This medicine is dispensed with a doctor’s prescription only
IPRATRIM
Inhaler
Each puff releases:
20 mcg ipratropium bromide
Inactive ingredients and allergens: see section 2 under
‘Important information about some of this medicine’s
ingredients’, and section 6 ‘Additional information’.
Read the entire leaflet carefully before you start
using
this
medicine. This
leaflet
contains
concise
information about this medicine. If you have any further
questions, consult your doctor or pharmacist.
This medicine has been prescribed to treat your illness.
Do not pass it on to others. It may harm them, even if it
seems to you that their illness is similar to yours.
1. What is this medicine intended for?
For relief of symptoms of reversible bronchospasm in case
of asthma, chronic bronchitis, and emphysema.
Therapeutic group: anticholinergic.
IPRATRIM is an inhaler that dilates the airways in cases
of constriction of the bronchial muscles (bronchospasm),
so that you can breathe more easily and freely.
2. Before using this medicine
Do not use this medicine if:
•
You are sensitive (allergic) to the active ingredient
ipratropium
bromide,
to
atropine
or
atropine
derivatives (anticholinergic substances with similar
structure) or to any of the other ingredients in this
medicine (see section 6).
•
You
are
pregnant
(particularly
during
the
first
trimester) or are breastfeeding, unless your doctor
has recommended this treatment after weighing the
risks and benefit.
Special warnings about using this medicine
•
Consult your doctor or pharmacist before using this
medicine.
•
Make sure that the solution or medicine mist does not
get in your eyes.
•
Use IPRATRIM with caution if you have a tendency to
narrow-angle glaucoma.
If the medicine accidentally gets in your eyes during
use, mild and reversible eye complications may occur.
Especially patients with elevated intraocular pressure
(narrow-angle
glaucoma)
may
experience
an
acute
gla
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Infovoldik Infovoldik araabia 04-12-2023
Infovoldik Infovoldik heebrea 03-12-2023

Vaadake dokumentide ajalugu